Joint NIMH Center Seminar Series
The Joint NIMH Center Seminar Series is presented weekly by the JH CAHN Administrative Core in partnership with the NIMH and participating centers:
- University of California San-Diego HIV Neurobehavioral Research Center
- Temple University Comprehensive NeuroHIV Center
- University of Pennsylvania Penn Mental Health AIDS Research Center
Each Wednesday, trainees, junior and senior scientists share their work with colleagues interested in neuro-HIV from across the United States and abroad. Seminars are held virtually on Zoom at 12 p.m. Eastern.
2024 – 2025 Seminar Series
The 2024 – 2025 Series begins Wednesday, September 18, 2024, and ends May 21, 2025. Please sign up for the series – it’s free! You will receive the Zoom link and a weekly email announcement about that week’s speaker and topic.
Present at a Seminar
We are now scheduling presenters for the 2024-2025 seminar series. Present your neuro-HIV and mental health research, and receive feedback from a global community of colleagues.
- Speakers are asked to present for approximately 40-45 minutes followed by a moderated, interactive Q&A and discussion
- Trainees and junior scientists are encouraged to present with a colleague or mentor.
Visit the seminar calendar to see open dates and reserve your spot to present:
Past Seminar Recordings
The Blood Brain Barrier Demonstrates Capability to Influence Heterogenous Tenofovir and Emtricitabine Metabolism and Transport in the Brain | Hannah Wilkins, M.S., Ph.D. Candidate (11/6/2024)
Giving HAND a Helping Hand: A Role for Neuroimaging | Beau Ances, M.D., Ph.D. (10/23/2024)
Brain Macrophages and Amyloid: 35 years of NeuroHIV Research | Cristian Achim, M.D., Ph.D. (10/16/2024)
Cumulative Burden of Depression and Domain-Specific Cognitive Impairment in the Women's Interagency HIV Study: A Marginal Structural Model Approach | César Higgins Tejera, Ph.D. (9/25/2024)
Suicide Risk Reduction Among People with HIV | Lily Brown, Ph.D. (11/8/23)
November 1, 2023: "miRNA Export, Transport and Uptake via Extracellular Vesicles in Mammalian Cells" Suvendra Bhattacharyya, PhD
October 25, 2023: "Brain N-acetyl-Aspartyl-Glutamate (NAAG) is Positively Associated with Cognitive Function" Robyn Wiseman, PhD Candidate; and "Tryptophan-Kynurenine Pathway Activation and Daytime Disruption in Women with HIV" Eran Shorer, MD
October 18, 2023: "Acidic Nanoparticles Prevent HIV Pre-exposure Prophylaxis (PrEP) Inhibition of Oligodendrocyte Maturation" Caela Long, PhD Candidate
October 11, 2023: "Measuring Routine and Behavioral Variability Through Smartphone-based Digital Phenotyping" Ian Barnett, PhD
September 27, 2023: "Proviral Location Affects Virus Production and Immune Recognition of HIV-1–infected T cell Clones" Francesco Simonetti, MD, PhD
April 5, 2023: "Dolutegravir inhibits oligodendrocyte differentiation through activation of the integrated stress response" Marisa Jeffries, PhD and “What have we learnt from the RV254 Thai acute HIV cohort” Philip Chan, PhD
March 22, 2023: "Osteopontin promotes cardiac fibrosis in HIV infection" Jake Robinson
March 8, 2023: "Broadly neutralizing anti-HIV antibodies (bNAb) and the CNS" Lucio Gama, PhD
March 1, 2023: "Human microglia phenotypes in the brain associated with HIV infection" Johannes Schlachetzki, MD
February 8, 2023: “Neurologic post-acute sequelae of COVID-19 preliminary findings and directions for future research” Lindsay McAlpine, MD; and "Single Copy HIV and Neurodegeneration, Oxidative Stress, and Neuroinflammation" Albert Anderson, MD
February 1, 2023: "Why do white matter dysfunction and myelin loss persist in HIV+ individuals despite effective antiretroviral therapy?" Judith Grinspan, PhD
January 18, 2023: "Establishing iPSC derived models to study HIV latency and microglia phenotypes" Sheetal Sreeram
January 11, 2023: “Multimodal MRI evidence of frontostriatal alterations in HIV and aging” Shiva Hassanzadeh-Behbahani, PhD; and “Cerebrospinal fluid virome in ART-treated adult people living with HIV” Mattia Trunfio, PhD Candidate
January 4, 2023: "Neutral sphingomyelinase 2 regulates the late stages of HIV assembly and maturation" Norman Haughey, PhD
Progressive Neurocognitive Impairments and Neuronal Injury Resulting From Chronic HIV-1 Viral Protein Exposure
The Self-Serving Side of Astrocytes: It’s All About ME!
Choices in HIV Pre-Exposure Prophylaxis: Today, Tomorrow, and Over-the-Horizon
Mitochondrial Alterations in HIV- and ART-Associated Neurotoxicity
Lysosomal De-acidification by the Antiretroviral Bictegravir Inhibits Oligodendrocyte Maturation
Lentiviral infections persist in brain despite effective antiretroviral therapy and neuroimmune activation
